Abstract
Until now, no suitable tumour marker is available for monitoring of patients with kidney cancer. However, some markers might be useful at least a bit, for example carcinoembryonic atigen and orosomucoid.
Until now, no suitable tumour marker is available for monitoring of patients with kidney cancer. However, some markers might be useful at least a bit, for example carcinoembryonic atigen and orosomucoid.